Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Gynecologic 1 Gastrointestinal 1

Conditions

Ovarian Carcinosarcoma 1

Interventions

Specimen Handling 39 Magnetic Resonance Spectroscopy 33 Cyclophosphamide 30 Doxorubicin 24 Biopsy 24 pembrolizumab 22 Temozolomide 22 Radiotherapy 20 Radiation 19 X-Rays 18 Nivolumab 15 Vincristine 13 Irinotecan 13 fludarabine 12 Phantoms, Imaging 12 Ifosfamide 12 Gemcitabine 12 atezolizumab 11 cabozantinib 10 Ipilimumab 9 Bevacizumab 9 liposomal doxorubicin 8 Surgical Procedures, Operative 8 Paclitaxel 8 Immunoglobulin G 8 Etoposide 8 Dactinomycin 7 Carboplatin 7 palbociclib 6 olaparib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Antineoplastic Agents × Sarcoma × 90 days × Clear all

NCT03651206 2026-06-01

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡